N-(pyridine-2-yl)-4-(4,4,5,5-tetramythyl-1,3,2-dioxaborolan-2-yl) benza
INR 750INR 780
In stock
Description
The term refers to a specific chemical compound, N-(pyridine-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-
yl)benzamide, which is an intermediate used in the synthesis of the cancer medication acalabrutinib
CAS No: -1383385-64-5
Specifications
| Molecular Formula: | C18H21BN2O3cap C sub 18 cap H sub 21 cap B cap N sub 2 cap O sub 3 |
|---|---|
| Molecular Weight: | 324.19 g/mol |
| Appearance: | White to off-white solid |
| Purity: | Typically listed as ≥97%is greater than or equal to 97 % |
| Packing :- | Powder form :- 25 Kg in HEDP bag with 2 liners (5 layer protected bag) |
| Shelf Life:- | (CAS NO. 1383385-64-5) is typically stated as 24 months. However, this is dependent on proper storage conditions. |
| Synonyms:- | N-(pyridin-2-yl)-4-(4,4,5,5-tetramethyl-[1, 3, 2]dioxaborolan-2-yl)benzamide, N-2-Pyridinyl-4-(4,4,5,5- tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide, 4-(2-Pyridylcarbamoyl)phenylboronic acid pinacol ester, Benzamide, N-2-pyridinyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, Acalabrutinib Intermediate 2 |